Levothyroxine - NDC Database (Page 20)
24201-002 Nov 15, 2022
Levothyroxine Sodium 100 ug/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
Levothyroxine Sodium 100 ug/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
25021-468 Jan 01, 2024
Levothyroxine Sodium 100 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
Levothyroxine Sodium 100 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
25021-469 Jan 01, 2024
Levothyroxine Sodium 200 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
Levothyroxine Sodium 200 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
25021-470 Jan 01, 2024
Levothyroxine Sodium 500 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
Levothyroxine Sodium 500 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.